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The cystatin family comprises cysteine protease inhibitors distributed in 3 subfamilies
(I25A–C). Family members lacking cystatin activity are currently unclassified. Little is
known about the evolution of Schistosoma cystatins, their physiological roles, and
expression patterns in the parasite life cycle. The present study aimed to identify
cystatin homologs in the predicted proteome of three Schistosoma species and
other Platyhelminthes. We analyzed the amino acid sequence diversity focused in
the identification of protein signatures and to establish evolutionary relationships
among Schistosoma and experimentally validated human cystatins. Gene expression
patterns were obtained from different developmental stages in Schistosoma mansoni
using microarray data. In Schistosoma, only I25A and I25B proteins were identified,
reflecting little functional diversification. I25C and unclassified subfamily members were
not identified in platyhelminth species here analyzed. The resulting phylogeny placed
cystatins in different clades, reflecting their molecular diversity. Our findings suggest that
Schistosoma cystatins are very divergent from their human homologs, especially regarding
the I25B subfamily. Schistosoma cystatins also differ significantly from other platyhelminth
homologs. Finally, transcriptome data publicly available indicated that I25A and I25B
genes are constitutively expressed thus could be essential for schistosome life cycle
progression. In summary, this study provides insights into the evolution, classification, and
functional diversification of cystatins in Schistosoma and other Platyhelminthes, improving
our understanding of parasite biology and opening new frontiers in the identification of
novel therapeutic targets against helminthiases.
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INTRODUCTION
Five species of the genus Schistosoma (Trematoda) are involved in
the human infection, being the main etiologic agents of human
schistosomiasis: Schistosoma mansoni and Schistosoma japonicum
causing intestinal schistosomiasis, and Schistosoma haematobium
causing urinary schistosomiasis. According to the World Health
Organization, schistosomiasis is endemic in 77 countries, affects
more than 200 million people worldwide, and other 779 million
live in areas at risk of infection (WHO, 2012). Schistosomiasis
control relies mainly on praziquantel treatment but its efficacy
is limited. Furthermore, evidence of praziquantel resistant par-
asites was obtained in the laboratory and in endemic regions
(Liang et al., 2003; Melman et al., 2009; Coeli et al., 2013). Hence
schistosomiasis is still one of the most prevalent infectious and
parasitic diseases worldwide being a major source of morbidity
and mortality in developing countries.
The urgent need to develop novel drugs or a vaccine for
Schistosoma species has encouraged an interest in the function
prediction of relevant proteins for parasitism. The search for new
drug targets based on evolutionary analyses using S. mansoni
genomic/proteomic data has been performed (Silva et al., 2011,
2012). Such studies have improved the S. mansoni functional
annotation, allowed for a deeper understanding of the genomic
complexity and lineage-specific adaptations potentially related to
the parasitic lifestyle, and pointed out several proteins as potential
drug targets, including proteases.
Cysteine proteases, one of the four major classes of prote-
olytic enzymes, have been found in a wide range of taxonomic
groups, from viruses to vertebrates. These peptidases are involved
in many biological processes, such as catabolism, antigen process-
ing, inflammation, dystrophy, and metastasis (Henskens et al.,
1996). Protease inhibitors, such as cystatins, inhibit the enzy-
matic activity of cysteine proteases. Cystatins comprise a family
of cysteine protease inhibitors identified in diverse taxonomic
groups, including Platyhelminthes and Nematoda (Kordis and
Turk, 2009). In humans, cystatins have evolved widely not only
to regulate enzymes in pathways but also as a defense mecha-
nism against proteases of invading pathogens (Toh et al., 2010).
www.frontiersin.org July 2014 | Volume 5 | Article 206 | 1
Cuesta-Astroz et al. Evolutionary analysis of Schistosoma cystatins
In parasites, cystatins participate in normal physiological pro-
cesses, but are also important pathogenicity factors, being directly
involved in host-parasite interactions (Hartmann et al., 1997;
Manoury et al., 2001; Schierack et al., 2003; Harnett, 2014).
Based on sequence similarity, the presence or lack of disul-
fide bonds, and physiological localization, cystatins were first
classified in three families: family 1 (e.g., stefins), family 2
(e.g., cystatins), and family 3 (e.g., kininogens) (Barrett, 1986).
Afterwards, in terms of number of cystatin domains and the pres-
ence of sequence features these proteins were classified into type
1, 2, and 3 (Rawlings and Barrett, 1990). In the present study
we adopted the classification proposed by MEROPS database a
resource for peptidases and protein inhibitors (Rawlings et al.,
2014). The database uses a hierarchical structure-based classifica-
tion in which each peptidase and inhibitor amino acid sequences
are grouped into families based on statistically significant simi-
larities. MEROPS classifies cystatin proteins as members of the
I25 family, further subdivided into four subfamilies: I25A, I25B,
I25C, and unclassified (Figure 1). This classification system is
based on similarities between protein sequences and three dimen-
sional structures. According to MEROPS classification, proteins
containing a single inhibitor unit are termed simple inhibitor,
and those containing multiple inhibitor units are termed as a
compound inhibitor (Rawlings et al., 2014). However, several
proteins containing cystatin domains cannot be easily included
in a classification scheme, resulting in a number of cystatin fam-
ily members that remain without classification in the subfamily
level (Cornwall et al., 2003; Kordis and Turk, 2009; Siricoon et al.,
2012).
One of the first cystatin proteins described in parasitic organ-
isms was the onchocystatin (I25B), a highly antigenic protein
encoded by the nematode Onchocerca volvulus (Lustigman et al.,
1991, 1992). Onchocystatin was initially proposed to be involved
in parasite protease regulation during the molting process in
Nematoda. Afterwards, it was shown that this protein is also
involved in modulation of host immune responses (Hartmann
et al., 1997). The molecular interactions of parasite cystatins and
host molecules have not yet been clearly determined, but it is
believed that the mechanisms are similar to those demonstrated
for other species (Klotz et al., 2011). Some examples of known
host parasite interactions were previously described in nematodes
in which I25B secreted cystatins inhibit host cathepsins such as B
and H by Haemonchus contortus (Newlands et al., 2001), L and S
by Acanthocheilonema viteae (Vray et al., 2002), and B and L by
Nippostrongylus brasiliensis (Dainichi et al., 2001).
Although cystatin family members have been the subject of
many studies in different organisms, little is known regarding
functional diversification and evolution in Schistosoma. In this
context, the information available for human homologs can be
used in comparative studies, at sequence and structure level,
in order to understand the interactions of Schistosoma cystatins
and host cysteine proteases. The present study aimed to identify
cystatin homologs on predicted proteomes of three Schistosoma
species and other Platyhelminthes in order to have a landscape
FIGURE 1 | Cystatin classification. The I25 family is classified in three subfamilies (I25A–C) according to MEROPS. Several family members remain
unclassified. UniProt accession numbers of human homologs are listed.
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view of the functional diversification in this phylum. In addi-
tion, evolutionary analyses were reconstructed for Schistosoma
and human homologs based on the information at the sequence
level, signatures, and phylogenetic relationships. Additionally, we
evaluated cystatins’ expression in different stages of the para-
site life cycle in order to answer the following questions: How
many cystatin homologs are present in Schistosoma species and in
other Platyhelminthes? Do potential homologs have characteristic
sequence features? What are the evolutionary relationships of the
cystatin family members in Schistosoma species and their human
homologs? Is the transcription of cystatin members during the
S. mansoni life cycle stage-specific or is it conserved through the
stages assessed?
In summary, we used predicted proteome data currently avail-
able for three Schistosoma species (Berriman et al., 2009; Zhou
et al., 2009; Young et al., 2012), three Cestoda (Tsai et al., 2013),
and the free living Schmidtea mediterranea (unpublished data) to
identify potential cystatin homologs encoded by Platyhelminthes.
Using combined computational approaches, we identified pro-
teins belonging to the I25 family and reported members classified
in two subfamilies: I25A and I25B. We also assessed microar-
ray public datasets to investigate gene expression in different
stages of the Schistosoma mansoni life cycle. This study provides
insights into the evolution and potential functional diversifica-
tion of Platyhelminthes cystatins improving our understanding of
parasite biology and opening new frontiers in the identification of
novel therapeutic targets against helminthiases.
MATERIALS AND METHODS
ORGANISMS AND SEQUENCE DATA
The dataset of selected species comprises three Schistosoma
species: S. haematobium (NCBI taxid: 6185), S. japonicum (6182),
and S. mansoni (6183); four other Platyhelminthes: Echinococcus
granulosus (6210), Hymenolepis microstoma (85433), Schmidtea
mediterranea (412041), and Taenia solium (6204); andHomo sapi-
ens (9606). Schistosoma predicted proteomes were downloaded
from SchistoDB 3.0 (beta.schistodb.net) (Zerlotini et al., 2013).
Cestoda proteome data was obtained from the Sanger Institute
FTP site (ftp.sanger.ac.uk/pub/pathogens). S. mediterranea pro-
teome data was kindly provided by Dr. Eric Ross from Stowers
Institute for Medical Research (USA). Predicted proteomes from
each genome project were used in order to obtain evidence of
protein gain or loss and a more accurate identification of cys-
tatin homologs. H. sapiens I25 family members were retrieved
from the Human Protein Reference Database (www.hprd.org)
(Keshava Prasad et al., 2009). Functional information regarding
the cystatin family is available on theMEROPS peptidase database
(Rawlings et al., 2014) via the I25 inhibitor family identifier.
HOMOLOGS IDENTIFICATION
Potential cysteine protease inhibitors encoded by platyhelminth
genomes were identified by using the hmmscan software included
in the HMMER 3.0 package (Eddy, 2011). Each proteome was
compared against Pfam-A HMM profiles, which were retrieved
from the Pfam database (Finn et al., 2014). Such analyses were
performed in order to identify the presence and architecture of
proteins comprising the cystatin domain (Pfam: PF00031). The
significance of the Pfam-A match is based on the resulting score.
A match is considered significant when the score is greater than
or equal to the gathering threshold for the Pfam domain. To date,
the current threshold for the cystatin domain (Pfam: PF00031) is
20.9. Proteins containing significant or insignificant matches with
the target domain were selected. Insignificant matches although
less informative than significant ones, can be used for identify-
ing functionally conserved regions when no significant matches
are found. For this reason, insignificant matches were also ini-
tially selected in this work. In addition, information on accessory
domains and protein signatures (Q-x-V-x-G motif, PW motif,
LP motif, SND/SNS/TNDmotifs, and disulfide bonds) were con-
sidered to define potential I25 homologs. The presence of signal
peptide in potential cysteine protease inhibitors was predicted by
SignalP 4.1 using the neural network method with default D-
cutoff values and using eukaryotes as “organism group” (Petersen
et al., 2011). The illustrations of protein domain architectures
were generated using DOG 2.0 (Ren et al., 2009).
PHYLOGENETIC ANALYSIS
Aiming at establishing evolutionary relationships among
Schistosoma and experimentally validated human cystatins, I25A
and I25B amino acid domain sequences from S. haematobium,
S. japonicum, S. mansoni, and H. sapiens were selected for
phylogenetic reconstruction. The evolutionary relationships
between Schistosoma and human cystatins may provide cues
about functions performed by parasites’ orthologs. Human
PF00031 domains classified into I25C subfamily or inhibitor
units not assigned to a subfamily were not included in this
analysis once they have no cysteine protease inhibitor activity.
To optimize the dataset for phylogenetic analysis we removed
redundancy and sequences too distantly related using the
Decrease Redundancy tool, available as a resource at ExPaSy
(www.expasy.org). The Decrease Redundancy parameters were
set as 98 for “% max similarity” and 30 for “% min similarity.”
The filtered set of amino acid sequences, corresponding to
the conserved domain (PF00031) were aligned using MAFFT
7 with iterative refinement by the G-INS-i strategy (Katoh
et al., 2009). The multiple sequence alignment comprising
22 sequences and 96 sites was manually refined using Jalview
(Waterhouse et al., 2009) and further used in phylogenetic
analysis. To reconstruct the phylogenetic tree we used MrBayes
3.2.1, which performs Bayesian inference using a variant of the
Markov Chain Monte Carlo (Ronquist and Huelsenbeck, 2003).
MCMC analyses were run as four chains, one cold and three
heated chains, for 10,000,000 generations and sampled every
100 generations. Twenty-five percentage of the initial samples
were discarded as “burn-in.” Mixed models were applied as a
parameter to estimate the best-fit evolutionary model. Support
values were estimated as Bayesian posterior probabilities. The
evolutionary history of Schistosoma and human cystatins was
also reconstructed based on the maximum likelihood method
(ML), as implemented in PhyML (Guindon et al., 2010). For the
phylogenetic reconstruction we tested 12 different evolutionary
models (JTT, LG, DCMut, MtREV, MtMam, MtArt, Dayhoff,
WAG, RtREV, CpREV, Blosum62, and VT) using the ProtTest
2.4 software (Abascal et al., 2005). The evolutionary model best
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fitting the data (best fit model) was determined by comparing
the likelihood of the tested models according to the Akaike
Information Criterion. Trees were visualized and edited using the
FigTree software (tree.bio.ed.ac.uk/software/figtree).
TRANSCRIPTIONAL PROFILES
Data from 35,437 oligonucleotide microarray probes from
S. mansoni transcriptomic analyses (Fitzpatrick et al., 2009)
were interrogated in order to identify the transcription pat-
terns of two cystatin family members: Smp_006390 (I25A) and
Smp_034420.2 (I25B). Thirteen development stages were covered
and the complete set of raw and normalized data were down-
loaded from ArrayExpress (https://www.ebi.ac.uk/arrayexpress/)
under the experiment accession number E-MEXP-2094. For dif-
ferential expression analysis, mean fluorescence normalized val-
ues were linear model fitted using three replicates per stage and
a total of 19 evolutionary pairwise comparisons were made (see
Fitzpatrick et al., 2009 for details). Additionally, recently pub-
lished RNAseq transcription data (Protasio et al., 2012) was also
interrogated for gene expression pattern and gene model eval-
uation. In this case, four developmental stages of S. mansoni
were covered. Raw sequence datasets (three from cercariae stage,
two from 3 h post-infection mechanically transformed schisto-
somula, two from 24 h post-infection schistosomulas, and one
from adult worms), were downloaded from ArrayExpress under
the accession number E-MTAB-451. The RNAseq reads were
stored in a local server and aligned to the most recent version of
the S. mansoni genome (v.5). Reads were mapped with Tophat-
v.2.0.8 (Trapnell et al., 2012) and transcripts were assembled with
Cufflinks-v.2.0.2 (Trapnell et al., 2012). Cuffdiff, a program from
the Cufflinks suite, was used to estimate expression of transcripts
across samples. CummeRbund, an R package, and Integrative
Genomics Viewer -IGV (Thorvaldsdóttir et al., 2013) were used
to visualize results.
RESULTS
In this study we have mined platyhelminth proteomes in order
to identify proteins belonging to the I25 family and its respective
subfamilies. To this end, we used intrinsic methods at sequence
level followed by multiple sequence alignment and phyloge-
netic analysis. Such analyses generated an evolutionary view of
potential cystatin proteins in three Schistosoma species. We also
analyzed the amino acid sequence diversity focused on the iden-
tification of protein signatures. Finally, we verified the transcrip-
tional profiles of cystatins. Overall, a framework for functional
analysis of parasite cystatins is provided. In summary, our find-
ings contribute to a better understanding of host-parasite inter-
actions and pathogenesis, once analysis and cystatins appear as
relevant molecules in these processes.
IDENTIFICATION OF CYSTATIN FAMILY MEMBERS
Cystatin family (I25) members were identified using an intrin-
sic method. Platyhelminth proteomes were scanned by hmmscan
(Eddy, 2011) and potential homologs were retrieved based on
the presence of significant or insignificant matches with the
conserved cystatin domain (PF00031) (Table 1). In cases where
insignificant PF00031 matches were recovered, we also searched
for critical residues that mediate protease inhibition to define the
query protein as a potential cysteine protease inhibitor (Table 2).
Based on “start” and “end” alignment positions of potential
homologs identified overlapping the PF00031 HMM profile,
truncated regions were assigned. It is important to emphasize
that the Pfam database (Finn et al., 2014) is built from the most
recent UniProt (UniProt Consortium, 2014) release and that no
single protein database covers all diversity existing in nature.
More specifically, the total of platyhelminth cystatins available
at UniProt is underrepresented when compared, for instance,
to mammals. Thus, it is possible that the presence of divergent
regions reflects their degree of divergence to other proteins avail-
able at the database. On the other hand, it is also important to
consider that the difference between the PF00031 HMM pro-
file and the query sequences can be related to the presence of
pseudogenes or errors in the gene models.
Considering alternative splicing products (Smp_034420.1,
Smp_034420.2, and Smp_034420.3; Sha_109477 and Sha_
109478), we identified in Schistosoma species ten proteins that
contain the conserved domain (Table 1). Three proteins were
retrieved in S. haematobium, three in S. japonicum, and four
in S. mansoni. These single domain proteins vary in length and
in domain size. In order to classify the identified homologs in
subfamilies (I25A–C or unclassified), we searched for the pres-
ence of signal peptide and other evolutionarily conserved residues
(Table 2), which are involved in the formation of a wedge-like
structure that is complementary to the active site of target pro-
teases. Features as Q-x-V-x-G, LP, and PW motifs which are
considered essential for binding and inhibiting cysteine pro-
teases activity were identified. To remove potentially redundant
sequences as well as too distantly related proteins we filtered
alternative splicing products and run the Decrease Redundancy
program using the previously mentioned parameters. In total,
four sequences were filtered out: Sha_109478, Sjc_0094540, Smp_
034420.1, and Smp_034420.3.
Concerning other Platyhelminthes species, we identified 14
cystatin proteins encoded by three Cestoda (E. granulosus,
H. microstoma, and T. solium) and a free living Turbellaria
(S. mediterranea) (Table 1). Contrary to Schistosoma species,
hmmscan searches retrieved additional domains in some of those
homologs. Such domains were retrieved as insignificant matches
and a few showed overlapping regions with the conserved domain
(PF00031) (Table 1). The information of additional domains may
suggest potential lineage-specific innovations that happened in
cystatin family members over evolutionary time. On the other
hand, it can reflect the caveat of data quality in organisms for
which we have only draft genomes.
We also analyzed cystatin diversity at the sequence level in
terms of critical motifs, amino acid conservation, or variants that
could lead to differences in the inhibitory capability of the cys-
tatins (Table 2 and Figure 3). The alignment of identified I25A
and I25B cystatin sequences point out four conserved regions: a
Glycine residue within the N-terminal region, a Q-x-V-x-G motif
in one hairpin loop, and a PW or LP motifs in the second loop
(Figure 3). Those regions can dock with the substrate-binding site
of family C1 of cysteine proteases (Dickinson, 2002). One disul-
fide bridge exclusively present in I25B proteins was also identified.
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Table 1 | Cystatin predictions across Schistosoma and other Platyhelminthes.
Taxon TaxID Accession Length Domain Start End E -value Score Significant
Schistosoma haematobium 6185 Sha_109477 160 PF00031 83 142 2.2×10−1 11.6 No
Sha_109478 145 PF00031 38 127 4.5×10−2 13.8 No
Sha_300402 101 PF00031 35 91 1×10−6 28.7 Yes
Schistosoma japonicum 6182 Sjc_0005780 145 PF00031 37 126 1.2×10−8 35 Yes
Sjc_0066340 101 PF00031 40 88 2.7×10−7 30.6 Yes
Sjc_0094540 123 PF00031 40 85 1.8×10−4 21.5 Yes
Schistosoma mansoni 6183 Smp_006390.1 101 PF00031 35 91 1×10−5 25.5 Yes
Smp_034420.1 117 PF00031 38 98 8.3×10−7 29 Yes
Smp_034420.2 148 PF00031 38 129 7.9×10−8 32.3 Yes
Smp_034420.3 145 PF00031 38 126 1.5×10−2 15.3 No
Echinococcus granulosus 6210 EgrG_000159200.1 98 PF00031 16 77 4.5×10−5 23.5 Yes
EgrG_000159200.1 98 PF03672 29 51 2.2×10−3 17.5 No
EgrG_000543900.1 111 PF00031 34 79 5.1×10−3 16.9 No
EgrG_000849600.1 274 PF00031 45 98 2.3×10−10 40.4 Yes
EgrG_000849600.1 274 PF00031 167 224 4.8×10−2 13.7 No
EgrG_000849600.1 274 PF13549 37 104 1.1×10−1 11.7 No
Hymenolepis microstoma 85433 HmN_000582300.1 180 PF00031 41 83 2.4×10−2 14.7 No
HmN_000582400.1 107 PF00031 26 78 1.5×10−2 15.4 No
HmN_000582400.1 107 PF06050 18 51 4.4×10−2 12.5 No
HmN_000842000.1 295 PF00031 63 115 3.2×10−4 20.7 No
Taenia solium 6204 TsM_000671000 274 PF00031 45 98 5.2×10−10 39.3 Yes
TsM_000671000 274 PF00031 175 224 1.7×10−2 15.2 No
TsM_000687900 98 PF00031 9 76 2.6×10−4 21 Yes
TsM_000687900 98 PF03672 29 51 2.2×10−2 14.3 No
TsM_000687900 98 PF13805 8 73 7.1×10−2 12.2 No
TsM_001154200 115 PF00031 37 84 4×10−3 17.2 No
TsM_001154200 115 PF14073 37 85 1.4×10−1 11.9 No
TsM_001154200 115 PF15606 39 87 3×10−2 14.2 No
TsM_001154300 137 PF00031 33 95 1.2×10−4 22.1 Yes
Schmidtea mediterranea 412041 mk4.000249.00.01 93 PF00031 4 51 8.6×10−2 12.9 No
mk4.000249.04.01 93 PF00031 4 51 9.6×10−2 12.8 No
mk4.004385.02.01 119 PF00031 33 104 1.3×10−13 50.8 Yes
mk4.027397.00.01 176 PF00031 33 121 6.1×10−14 51.9 Yes
TaxID: identifier at NCBI taxonomy database. Accession: accession number in the source genome project database. Length: number of amino acids. Domain:
domain prediction based on HMM models from the Pfam database using the HMMscan tool. Start and End: alignment positions of the retrieved domain in the
query sequence. Significant (Yes/No): statistically significant or insignificant score values according to the gathering threshold for each Pfam domain.
I25A subfamily members are predominantly intracellular single-
domain proteins of about 11 kDa and ∼100 amino acid residues,
which do not contain disulfide bridges and the PW motif. I25A
inhibitors have three evolutionarily highly conserved regions: a
glycine residue within the N-terminal region, a central Q-x-V-x-G
motif, and a C-terminal LP pair (Klotz et al., 2011).
Figure 3 shows five Schistosoma and human homologs that
have these conserved features, being therefore classified into
the I25A subfamily. Following the same pattern of con-
served features, when analyzing the proteome data of others
Platyhelminthes (Table 2), we identified potential I25A subfam-
ily member in E. granulosus (EgrG_000159200.1) and in T. solium
(TsM_000687900). In H. microstoma three potential cystatin pro-
teins without signal peptide were identified, something uncom-
mon in other platyhelminth predictions. Therefore, this result
should be further evaluated carefully, before being considered
an evolutionary innovation. In S. mediterranea we identified two
proteins belonging to the I25A subfamily. However the identified
cystatins mk4.000249.04.01 and mk4.000249.00.01 are identi-
cal. For this reason we took into account the probability of
redundancy and considered one of them (Table 2) as a cystatin
homolog.
I25B inhibitors are secreted single-domain proteins around
14 kDa, ∼120 residues long with at least one disulfide bridge and
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Table 2 | Sequence features of I25 family members in selected taxa.
TaxID Accession SP SND/SNS/TND Q-x-V-x-G S-S LP PW
6185 Sha_109477 Yes N/A Yes Yes No Yes
Sha_109478 Yes N/A No Yes No Yes
Sha_300402 No N/A Yes No Yes No
6182 Sjc_0005780 Yes N/A Yes Yes No Yes
Sjc_0066340 No N/A Yes No Yes No
Sjc_0094540 No N/A Yes Yes No No
6183 Smp_006390.1 No N/A Yes No Yes No
Smp_034420.1 Yes N/A Yes Yes No No
Smp_034420.2 Yes N/A Yes Yes No Yes
Smp_034420.3 Yes N/A No Yes No Yes
6210 EgrG_000159200.1 No N/A Yes Yes Yes No
EgrG_000543900.1 Yes N/A Yes No No No
EgrG_000849600.1_x Yes N/A Yes No No Yes
EgrG_000849600.1_y No N/A No No No No
85433 HmN_000582300.1 No N/A Yes No No No
HmN_000582400.1 No N/A Yes No No No
HmN_000842000.1 No N/A Yes No No No
6204 TsM_000671000_x Yes N/A Yes No No Yes
TsM_000671000_y No N/A No No No No
TsM_000687900 No N/A Yes No Yes No
TsM_001154200 Yes N/A No No No No
TsM_001154300 Yes N/A Yes No No No
412041 mk4.000249.00.01 No N/A Yes No Yes No
mk4.000249.04.01 No N/A Yes No Yes No
mk4.004385.02.01 Yes N/A Yes Yes No No
mk4.027397.00.01 Yes N/A Yes Yes No Yes
9606 O60676_CST8 Yes No No Yes No Yes
O76096_CYTF Yes Yes Yes Yes No Yes
P01034_CYTC Yes Yes Yes Yes No Yes
P01036_CYTS Yes No No Yes No Yes
P01037_CYTSN Yes No Yes Yes No Yes
P01040_CYTA No No Yes No Yes No
P01042_KNG1 Yes No No Yes No No
P01042_KNG2 N/A No Yes Yes No No
P01042_KNG3 N/A No Yes Yes No Yes
P04080_CYTB No No Yes No Yes No
P09228_CYTSA Yes No Yes Yes No Yes
P28325_CYTD Yes No Yes Yes No Yes
Q15828_CYTM Yes Yes Yes Yes No Yes
Q5W186_CST9 Yes No No Yes No No
Q9H112_CST11 Yes No No Yes No Yes
Q9H114_CST1Like Yes Yes No Yes No Yes
Q9H4G1_CST9Like Yes No No Yes No Yes
TaxID: identifier at NCBI taxonomy database. 9606: Homo sapiens. Accession: accession number in the source genome project database or in UniProt (human
proteins). Sequence features include a signal peptide (SP), disulfide bridge (S-S), and distinct motifs (SND/SNS/TND, Q-x-V-x-G, LP, and PW), in which amino acids
are indicated by the one-letter code. Yes or No: presence or absence of conserved features. N/A: Not applicable.
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a signal peptide. I25B inhibitors have two of the three conserved
regions previously mentioned: the N-terminal Gly residue and a
central Q-x-V-x-G motif. Instead of a C-terminal LP pair, I25B
inhibitors have a PW motif at the C-terminal segment. Besides,
some I25B members also possess a distinct conserved SND, SNS
or TND motifs between the first conserved glycine and the
central Q-x-V-x-G motif (Table 2). The presence of these addi-
tional motifs allow cystatin proteins to inhibit either legumain
or asparaginyl endopeptidases (Alvarez-Fernandez et al., 1999;
Zavasnik-Bergant, 2008; Klotz et al., 2011; Schwarz et al., 2012).
In parasites, I25B subfamily members were demonstrated to be
involved in modulation of host immune responses (Khaznadji
et al., 2005; Gregory and Maizels, 2008). Figure 3 shows I25B
Schistosoma and human sequences identified according the
sequence features previouslymentioned. In three Platyhelminthes
species (E. granulosus, H. microstoma, T. solium) it was not pos-
sible to identify I25B homologs (Table 2). In S. mediterranea
we identified two similar sequences. However, it seems like that
mk4.004385.02.01 is a fragment of mk4.027397.00.01. In this case
we have chosen the mk4.027397.00.01 protein as potentially true
I25B homolog due to the presence of expected sequence features
(Table 2).
I25C subfamily members act mostly on serine proteases classi-
fied into the family S8 (Cornwall et al., 2003) and metallopro-
teases from the family M12 (Valente et al., 2001). Fetuins and
histidine rich proteins are also multi-domain secreted proteins,
but lack cystatin activity and are called as unclassified (Rawlings
et al., 2014). Kininogens and fetuins are much younger than I25A
and I25B proteins and their occurrence are restricted to verte-
brates (Kordis and Turk, 2009). According to our findings, the
I25C and unclassified subfamily members are not encoded by the
genomes of platyhelminth species here analyzed.
Human cystatin protein subunits previously characterized as
protease inhibitors were classified as belonging to one of the three
cystatin subfamilies 125A–C (Table 2). In total, 15 proteins were
retrieved from the Human Protein Reference Database (Keshava
Prasad et al., 2009) and evolutionarily conserved residues were
identified (Table 2 and Figure 3). As already described in the lit-
erature, one additional motif was found (SND/SNS/TND), which
is related to legumain inhibition. A multidomain protein P01042
was retrieved for each separate subunit denoted as KNG1, KNG2,
and KNG3 (Table 2).
EVOLUTIONARY RELATIONSHIPS AMONG SCHISTOSOMA AND H.
SAPIENS CYSTATINS
The evolutionary relationships in cystatins were reconstructed
from an alignment containing 22 sequences corresponding to the
conserved domain (PF00031) and 96 sites (Figure 3) using max-
imum likelihood and Bayesian inference. Both methods retrieved
the same tree topology. Statistical support was also calculated
for each node by both phylogenetic inference methods (Bayesian
inference/maximum likelihood). Protein sequences are repre-
sented on the phylogenetic tree by UniProt (UniProt Consortium,
2014) and SchistoDB (Zerlotini et al., 2013) identifiers. Based on
the phylogeny we were able to identify two well supported mono-
phyletic subfamilies (100/100): I25A and I25B (Figure 4). I25C
and unclassified homologs were not identified in Schistosoma
species. Two domains of the kininogen protein P01042 (KNG2
and KNG3) were placed in I25B clade due to its cysteine protease
inhibitory activity. The KNG1 domain from the same protein
belongs to the I25C subfamily and was not included in this anal-
ysis because it has lost its inhibitory activity due to mutations in
structurally important regions (Kordis and Turk, 2009) and may
act as a calcium transporter (Higashiyama et al., 1987).
According to the phylogeny (Figure 4), three Schistosoma pro-
teins (Sha_300402, Sjp_0066340, and Smp_006390.1) and two
human cystatin proteins (P04080_CYTB, P01040_CYTA) were
grouped into the I25A subfamily clade. These proteins share
the evolutionarily conserved residues: a N-terminal Gly, a cen-
tral Q-x-V-x-G, and a C-terminal LP (Table 2 and Figure 3).
Based on the information available on the literature and
in protein databases, both human homologs (P04080_CYTB,
P01040_CYTA) were experimentally and structurally character-
ized. On the other hand, only two I25A Schistosoma proteins
(Smp_006390.1 and Sjp_0066340) were experimentally charac-
terized at the protein level (Morales et al., 2004; He et al., 2011).
Those proteins are involved in a intracellular modulator role.
For instance, Smp_006390.1 was able to inhibit the formation of
hemozoin by live schistosomula, suggesting a possible role in the
gut of the schistosomula (Morales et al., 2004).
In I25B subfamily clade three Schistosoma homologs were
grouped with 13 human proteins (14 cystatin domains). The con-
served features (signal peptide, Gly residue, Q-x-V-x-G motif,
disulfide bridge, and PW motif) were not detected in all pro-
tein domain sequences (Table 2 and Figure 3). Contrary to
Schistosoma I25A subfamily members, I25B cystatins were not
experimentally characterized. Human sequences placed on the
I25B subfamily clade reveal a significant expansion of such sub-
family in H. sapiens. The phylogenetic analysis shows that these
homologs originated from successive post speciation gene dupli-
cation events. Most human I25B members present the typical
protein signatures (Table 2 and Figure 3).
In summary, Schistosoma cystatin clades of I25A and I25B
subfamily members were well supported by both branch sup-
port methods showing 100/100 (aLRT and posterior probability).
S. haematobium and S. mansoni cystatins are closest related to
each other when compare to the S. japonicum homolog. The phy-
logenetic analysis showed that human and Schistosoma cystatins
are placed in different clades, reflecting its diversity at molecular
level.
CYSTATIN EXPRESSION IN SCHISTOSOMAMANSONI
According to the microarray data analysis (Fitzpatrick et al.,
2009), both I25A and I25B members, Smp_006390.1 and
Smp_034420.2 respectively, were constitutively expressed in sev-
eral stages of the S. mansoni life cycle (Figure 5). These find-
ings corroborate the pairwise comparisons of key developmental
stages performed by Fitzpatrick et al. (2009) that did not indicate
any differential expression of both cystatin mRNAs. Comparisons
were made with an adjusted p value (Adj p < 0.05), corrected
using the Benjamini and Hochberg method for multiple testing,
for which 3 replicates per life cycle were assessed. Both cystatins
expression were also confirmed in the RNA sequencing work of
Protasio et al. (2012). Transcripts were expressed constitutively
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in all four stages evaluated (data not shown). No differential
expression assessment was considered in this case, mostly because
those experiments did not include adult worm sample replicates.
Therefore, without replicates, it is impossible to estimate sample
variability.
As RNAseq data can be used to improve gene model anno-
tations, current gene models for both I25A and I25B members
were investigated. We analyzed the read coverage by mapping the
reads against the reference genome. It was performed by Tophat, a
tool that allows read alignments containing gaps in regions span-
ning introns. Therefore, predicted gene models for both cystatin
family members were confirmed by visual inspection using IGV
(Thorvaldsdóttir et al., 2013). All three exons of I25A and four
exons of I25B, as well as both 5′ and 3′ UTR regions, located in
the S. mansoni SuperContig 0138 and chromosome 2 respectively,
had several reads correctly mapped within the exon limits (data
not shown).
DISCUSSION
CONSERVED SEQUENCE FEATURES IN CYSTATINS
The I25A cystatin subfamily is a predominantly intracellular pro-
tein and does not present disulfide bridges. The inhibitor domain
Q-x-V-x-G is present in the first hairpin loop and contains the
glycine residue in the first position of the cystatin domain. This
amino acid is also conserved in other cystatins of the I25B sub-
family (Figure 3). This glycine residue allows the N-terminal
region to interact with the sub-sites S4, S3, and S2 of the cysteine
proteases. In Schistosoma species, besides its role in degradation
of hemoglobin, I25A can also act intracellularly as a general regu-
lator of protease activity (Morales et al., 2004). The constant and
ubiquitous expression in S. mansoni, as shown by transcriptomic
analysis, supports this idea. In the I25A subfamily we identified
the highly conserved LP motif in positions 73–74 (Figure 3). The
LP motif is essential for high affinity binding to papain (Pol and
Bjork, 1999). The conserved motif differences between I25A and
I25B subfamilies could reflect differences in the inhibitory spec-
trum of these proteins during evolution of function (Dickinson,
2002).
Kordis and Turk (2009) postulated that the progenitor of
this family was most probably intracellular, lacked a signal pep-
tide and disulfide bridges. The hypothesis is that throughout
cystatins evolution, gene duplications combined with deletions
and insertions of genetic material resulted in single and multi-
domain proteins with or without disulpfide bonds, glycosylated
or not. Accordingly members of I25B subfamily likely evolved
from I25A ancestors, which lack cysteine residues, acquiring
disulfide bridges and signal peptide during evolutionary processes
(Brown and Dziegielewska, 1997; Gregory and Maizels, 2008). In
Schistosoma we identified a single I25B cystatin in each species, all
of them containing critical motifs (Table 2). On the other hand,
the E. granulosus protein EgrG_000849600.1 has signal peptide
and two cystatin domains. One of them has an insignificantmatch
with the PF00031 HMMprofile (Table 2 and Figure 2). This mul-
tidomain protein did not show disulfide bridges, which is not typ-
ical for secreted proteins. The T. solium protein TsM_000671000
displayed architecture very similar to E. granulosus (Table 2 and
Figure 2). Perhaps this indicates a protein architecture that is
lineage-specific of Cestoda, although both of these species fall
within the same cyclophyllidean family, and may not be repre-
sentative of all tapeworms. The H. microstoma cystatins displayed
an interesting protein architecture. They do not contain a signal
peptide and also lack the LP motifs, unlike other I25A members
(Table 2).
The legumain inhibitory motifs (SND/SNS/TND) are distinct
from the papain binding motif (Q-x-V-x-G) (Alvarez-Fernandez
et al., 1999). These sites are located on the opposite side of the
papain binding site (Gregory andMaizels, 2008) and were present
in four human sequences P01034_CYTC (SND), Q15828_CYTM
(SNS), O76096_CYTF (TND), Q9H114_CST1Like (SND) in
position 28 of the cystatin domain (Table 2 and Figure 3). In
Schistosoma and other Platyhelminthes, these motifs belonging to
bifunctional cystatins were not present. However, in the nema-
tode Brugia malayi the SND motif was identified in the secreted
cystatin Bm-CPI-2 and was able to block the activity of mam-
malian legumain (Manoury et al., 2001). This inhibition profile is
shared with other nematodes implying a dual function for nema-
tode cystatins. In terms of adaptation to parasitism, Hartmann
and Lucius (2003) compared I25B cystatins from filariae to those
ofC. elegans, and observed a distinct pattern of enzyme inhibitory
activity and immunological properties.
Our results point to the diversity in terms of the presence and
absence of sequence features used to classify cystatins (Table 2).
An accurate cystatin classification based just upon these features
is challenging. We used strict classification criteria, but we must
take into account that many of the genomes here analyzed are
still in their early versions and may contain inaccurate gene mod-
els, suggesting it is necessary to undertake manual curation for
unambiguous annotation of cystatins and other proteins.
PHYLOGENETIC RELATIONSHIPS IN THE CYSTATIN FAMILY
We identified two cystatin subfamilies, I25A and I25B, in the
Schistosoma-Human phylogeny (Figure 4). In this work, a com-
parative analysis of Schistosoma cystatins and other 15 experimen-
tally validated human cystatins belonging to diverse subgroups
provided insights into the abundance, diversity, and evolution of
Schistosoma cystatin family members. According to our results,
the I25 cystatin family has a few members in Schistosoma, includ-
ing I25A and I25B subfamilies’ representatives in each species.
Human cystatins have diversified significantly during the course
of evolution, both at the sequence and functional levels, indi-
cating that the cystatin domain is a protein-protein interaction
module that can interact with novel targets (Alvarez-Fernandez
et al., 1999; Dickinson, 2002; Abrahamson et al., 2003; Cornwall
and Hsia, 2003; Kordis and Turk, 2009).
A subgroup in the I25B subfamily, named Cres (cystatin-
related epididymal spermatogenic)/Testatin, was identified in
our study with statistical support 80/86. This clade comprises
I25B Schistosoma sequences. In human, glycoproteins of the
Cres/Testatin subgroup are expressed in reproductive tissues and
their function may be related to reproduction (Frygelius et al.,
2010). The topology of this subgroup showed in Figure 4 is con-
sistent with the phylogeny reported by Frygelius et al. (2010).
Interestingly this subgroup lacks the consensus Q-x-V-x-G motif
(Table 2 and Figure 3). Figure 4 shows that these proteins have a
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FIGURE 2 | Cystatin architecture in three Platyhelminthes. Accession
numbers correspond to those assigned in each genome project.
Domain limits (above) and sequence length (below) are provided for
each protein. A signal peptide (SP) and the conserved domain
(PF00031) with significant (blue) or insignificant (?) matches are
indicated.
common origin and may represent a new subgroup within I25
family. Phylogenetic and comparative analyses show that genes
involved in reproduction as Cres/Testatin and host pathogen
interaction are under strong positive selection (Frygelius et al.,
2010).
The phyletic distribution of the multidomain cystatins is
limited and phylogenomic analyses suggest that multidomain
cystatins are not monophyletic. Evidence suggests, they origi-
nated independently several times during evolution of eukaryotes
(Kordis and Turk, 2009). Kininogen proteins (e.g., P01042) are
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FIGURE 3 | Alignment of Schistosoma and human homologs. Multiple
sequence alignment of the conserved domain (PF00031) of I25A and I25B
proteins of S. haematobium (Sha), S. japonicum (Sjp), S. mansoni (Smp), and
Homo sapiens (UniProt accession numbers). Amino acid sequences were
aligned using MAFFT with iterative refinement by the G-INS-i strategy.
Conserved motifs (Q-x-V-x-G and PW) and disulfide bridges (S-S) are indicated.
multidomain and divergent cystatins containing three domains
with different inhibitory properties. In our phylogenetic analy-
sis we discarded the first domain as it lacks inhibitory activity
(Rawlings et al., 2014). The two remaining kininogen domains
(P01042_KNG2; P01042_KNG3) were placed in the I25B sub-
family clade. The P01042_KNG2 and P01042_KNG3 domains
contain the Q-x-V-x-G residues critical for inhibitory activity
(Table 2). Both domains are grouped together with other human
cystatins Q15828_CYTM and O76096_CYTF that inhibit both
cysteine and asparaginyl protease due to the presence of the SNS
and TND motifs, respectively (Table 2).
Our results suggest that Schistosoma species contain only two
cystatin subfamilies, reflecting little functional diversification.
Due to the presence of highly divergent sequences in I25B clade,
the recognition of orthologous sequences is a difficult task. The
intracellular cystatins belonging to I25A subfamily are more con-
served than the divergent extracellular cystatins (I25B) (Figure 3),
as reported for other proteins with similar features (Julenius and
Pedersen, 2006).
Khaznadji et al. (2005) reported the first I25A multidomain
protein in invertebrates, amultidomain I25A in the platyhelminth
Fasciola hepatica containing six cystatin like domains, two of
which are well conserved (Khaznadji et al., 2005). The intracellu-
lar and multidomain I25A inhibits parasite cathepsin L1 activity.
The methods used by Khaznadji et al. (2005) to determine the
domain architecture of this cystatin differs from those applied by
MEROPS (Rawlings et al., 2014), which indicates the presence
of a single domain in this protein. In addition, the presence of
multidomain proteins are not the only novelty in the cystatin fam-
ily, several I25A cystatins from unicellular eukaryotic organisms
have gained the signal peptide, which is absent in the majority of
metazoan and eukaryotic I25A cystatins. The presence of signal
peptide as observed in some unicellular eukaryotic I25A cystatins
(Kordis and Turk, 2009) and in Fasciola gigantica (Siricoon et al.,
2012) may lead to the gain of novel defense functions.
In synthesis, the major obstacle to the identification and clas-
sification of cystatins using amino acid sequences is the fact
that many of the proteins contain multiple homologous inhibitor
domains in a single protein (Rawlings et al., 2014). Furthermore,
phylogenetic analysis of cystatin family members is hampered by
short protein length often added to the sequence divergence. In
addition, different branches appear to have evolved at different
rates (Dickinson, 2002).
CYSTATIN EXPRESSION
In the present work, we interrogated publicly available gene
expression datasets in order to investigate mRNA expression
of both cystatin members I25A (Smp_006390.1) and I25B
(Smp_034420.2) in S. mansoni. Microarray data by Fitzpatrick
et al. (2009) assessed three ecological niches of S. mansoni life
cycle (freshwater, molluscan, and definitive vertebrate host) and
indicated similar expression levels of both cystatins among the
parasite life cycle (Figure 5). The constitutive expression may be
essential for schistosome life cycle progression. Published RNAseq
data (Protasio et al., 2012) also point to the expression of cystatins
in cercariae, schistosomula, and adults stages. Additional reports
(Morales et al., 2004) suggest that I25A is expressed equally by
adult males, females, and schistosomula stages. Therefore, both
I25A and I25B are expressed throughout the S. mansoni life cycle.
In S. japonicum, He et al. (2011) observed not just the expres-
sion levels of the stefin Sjp_0066340, a I25A subfamily member, in
egg, schistosomula, and adult stages by RT-PCR. He et al. (2011)
also performed immunohistochemistry studies, which revealed
that the S. japonicum stefin is mainly localized at the epithelial
cells lining the gut as well as the tegument on the surface of
adult worms. Additionally, the stefin of Clonorchis sinensis was
also found mainly localized in the epithelial cells lining the intes-
tine of the parasite (Kang et al., 2014). The stefin of F. gigantica
was also localized in the intestinal epithelium and the tegumental
type cell bodies together with the tegumental syncytium (Tarasuk
et al., 2009). Altogether, the expression of parasite I25A proteins
in the host-parasite interface point to a possible role in molecu-
lar interactions with host proteins, which are mostly inhibitors of
host cysteine proteases such as cathepsins (Tarasuk et al., 2009; He
et al., 2011; Kang et al., 2014).
Recently, an unusual secreted form of I25A member was char-
acterized in F. gigantica (Siricoon et al., 2012). Although this
awkward cystatin does present a signal peptide, typical of I25B
proteins, sequence analysis does correlate it to the I25A subfam-
ily. Nevertheless, Siricoon et al. (2012) provided evidence of a
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FIGURE 4 | Evolutionary relationships of I25A and I25B cysteine
protease inhibitors. A total of 22 amino acid sequences and 96 sites
comprising the conserved domain (PF00031) of homologs encoded by
S. haematobium (brown), S. japonicum (green), S. mansoni (blue), and
Homo sapiens (black) were analyzed. The phylogeny was reconstructed by
two methods using WAG was as the best fit model. In the Bayesian
inference, support values for each node were estimated as posterior
probability (above). In the maximum likelihood analysis, they were
estimated using the Akaike Likelihood Ratio Test (aLRT) (below). Only
support values higher than 70% are shown.
secreted form of a cystatin protein in Platyhelminthes that was
again observed in the intestinal epithelium in all developmen-
tal stages. Moreover, the secreted 125A protein was also found
expressed in the prostate gland in the adult stage of F. gigantica,
which suggests a regulative role of cysteine protease activity in
reproductive system. Similarly, the expression of human cystatin
I25B subgroup proteins, also called Cres/Testatin, was localized
at the reproductive tissues and their function may be related
to reproduction (Frygelius et al., 2010). Interestingly, human
Cres/Testatin subgroup was placed in the same clade with the
Schistosoma cystatins I25B (Figure 4).
Based on the evidence of expression in related organisms and
given the constitutive expression of cystatins I25A and I25B in
S. mansoni, it is possible that cystatin functions can be involved
in key processes in Schistosoma. Such proteins may be required
to keep its proteolytic activity balanced as well as to protect the
parasite against degradation by host or endogenous proteins.
Nevertheless, cystatin tissue-specific expression, such as those
FIGURE 5 | Cystatins mRNA expression patterns in the S. mansoni life
cycle. Public microarray data available at ArrayExpress (E-MEXP-2094) was
downloaded to a local server in order to identify cystatins expression
patterns of the I25A subfamily member Smp_006390 (A) and the I25B
subfamily member Smp_034420 (B) in S. mansoni. Bars correspond to the
mean normalized values for each oligonucleotide probe named
Smp_006390 and Smp_034420 in 13 different life stages.
identified at the reproductive system in human and F. gigantica,
could evidence a more specialized role against specific cysteine
proteases.
CONCLUSIONS
In summary, our evolutionary analysis using genomic, transcrip-
tomic, and proteomic data for three Schistosoma species and other
Platyhelminthes has provided the first insights into the evolution,
classification, and functional diversification of platyhelminth cys-
tatins. These findings improve our understanding concerning the
diversity, at the molecular level, of cystatins encoded by such
species. Only two subfamilies (I25A and I25B) were clearly iden-
tified in Schistosoma and Platyhelminthes reflecting the low diver-
sification of this family when compared to human. Regarding
Cestoda, it is necessary to implement an exhaustive study in order
to better understand the domain composition revealed in our
work.
We expect that this study will encourage experimental and
structural characterization of cystatins in Schistosoma and other
closely related parasites. Altogether, studies involving parasite cys-
tatins will help to elucidate the functions performed by those
proteins as well their correlation with parasite biology and host-
parasite interaction. The importance of new insights revealed
by functional genomics as RNAi experiments and comparative
expression patterns across different life cycle stages in Schistosoma
and other Platyhelminthes will provide a functional landscape of
the cystatin role in the parasite life cycle.
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